With the volume and price change over the last several months, we must be missing something. I do not believe the uplisting alone would generate that response, so my best guess is that there are new or expanded uses for the Freedom system or sub Q drug delivery.
You are the technical expert here. Do we go back and retest $5.20/$530 area? Is today a dead cat bounce before going below $5? Do you see a head and shoulder pattern here? The 6 month low is $1.50.